Certified by Founder Lodge
Laverock Therapeutics
United Kingdom - Stevenage, England
START UP
1 Disclosed Funding Rounds $16,470,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Next generation programmable cell therapies
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 28 ,2023 | Seed | $16,470,000 |
Eli Lilly and Company
Mercia Asset Management PLC
Maven Capital Partners
Eos
UK Innovation & Science Seed Fund
Tekfen Ventures
Calculus Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Leadbay (YC F25) | $4,300,000 | (May 20, 2026)
bunch | $35,000,000 | (May 20, 2026)
Benji | $6,250,000 | (May 20, 2026)
Vital Signals | $15,000,000 | (May 20, 2026)
Kin Health | $9,000,000 | (May 20, 2026)
